Physician profile
Christopher Bromley
NPI 1710926340
$152,108.95
in general payments reported to CMS, 2019-2025
42 companies · $45K in 2025
The $45K reported for 2025 was more than what 99% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $44K · 2021: $23K · 2022: $2,192 · 2023: $1,340 · 2024: $3,309 · 2025: $45K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $48K · Food and Beverage: $1,344 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $47,500.00 |
| Food and Beverage | $1,343.92 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $825.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fuse Medical, INC. | $67,458.71 | 2019-2020 | |
| Sanara Medtech INC. | $45,046.12 | 2021-2025 | |
| Heron Therapeutics, INC. | $14,722.50 | 2020-2022 | |
| Alfasigma USA, INC. | $6,513.88 | 2021-2022 | |
| Tosoh Bioscience, INC. | $4,006.00 | 2019 | |
| Tenex Health INC. | $3,934.03 | 2020-2021 | |
| Trice Medical, INC. | $2,893.05 | 2022-2024 | |
| Alexion Pharmaceuticals, INC. | $1,650.00 | 2021-2023 | |
| Paragon 28, INC. | $1,170.98 | 2019-2021 | |
| Next Science LLC | $785.20 | 2021 | |
| Tactile Systems Technology INC | $716.80 | 2019-2024 | Entre Plus, Flexitouch Plus |
| Organogenesis INC. | $445.88 | 2021 | |
| Cpm Medical Consultants, LLC | $359.16 | 2019-2020 | |
| Stryker Corporation | $290.97 | 2019-2020 | |
| Kerecis Limited | $261.85 | 2019-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Bromley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.